Jiangsu Apon Medical Technology Co., Ltd.

SZSE:300753 Stock Report

Market Cap: CN¥2.4b

Jiangsu Apon Medical Technology Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Zhi Hui Zhang

Chief executive officer

CN¥511.6k

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownershipn/a
Management average tenureno data
Board average tenure2.3yrs

Recent management updates

Recent updates

Here's What's Concerning About Jiangsu Apon Medical Technology's (SZSE:300753) Returns On Capital

Dec 05
Here's What's Concerning About Jiangsu Apon Medical Technology's (SZSE:300753) Returns On Capital

Optimistic Investors Push Jiangsu Apon Medical Technology Co., Ltd. (SZSE:300753) Shares Up 26% But Growth Is Lacking

Dec 05
Optimistic Investors Push Jiangsu Apon Medical Technology Co., Ltd. (SZSE:300753) Shares Up 26% But Growth Is Lacking

Jiangsu Apon Medical Technology Co., Ltd.'s (SZSE:300753) Share Price Boosted 39% But Its Business Prospects Need A Lift Too

Oct 09
Jiangsu Apon Medical Technology Co., Ltd.'s (SZSE:300753) Share Price Boosted 39% But Its Business Prospects Need A Lift Too

Insufficient Growth At Jiangsu Apon Medical Technology Co., Ltd. (SZSE:300753) Hampers Share Price

Jul 02
Insufficient Growth At Jiangsu Apon Medical Technology Co., Ltd. (SZSE:300753) Hampers Share Price

Jiangsu Apon Medical Technology Co., Ltd.'s (SZSE:300753) Share Price Boosted 41% But Its Business Prospects Need A Lift Too

Mar 08
Jiangsu Apon Medical Technology Co., Ltd.'s (SZSE:300753) Share Price Boosted 41% But Its Business Prospects Need A Lift Too

CEO

Zhi Hui Zhang (53 yo)

no data

Tenure

CN¥511,600

Compensation

Mr. Zhi Hui Zhang serves as General Manager, Managing Director and Director of Jiangsu Apon Medical Technology Co., Ltd.


Board Members

NamePositionTenureCompensationOwnership
Zhi Hui Zhang
GM, MD & Directorno dataCN¥511.60kno data
Ningyu Wang
Chairmanno dataCN¥541.10k28.62%
CN¥ 688.2m
Jifeng Guan
Directorno datano data0.47%
CN¥ 11.3m
Lizhong Wang
Non-Independent Director2.3yrsno datano data
Xiangyong Kong
Independent Director2.3yrsCN¥120.00kno data
Liyang Hou
Independent Director2.3yrsCN¥120.00kno data
Hongxun Tao
Independent Director2.3yrsCN¥120.00kno data
Hao Tang
Supervisor2.3yrsno datano data
Xinchuang Yuan
Supervisory Board Chairman2.3yrsno datano data

2.3yrs

Average Tenure

53yo

Average Age

Experienced Board: 300753's board of directors are not considered experienced ( 2.3 years average tenure), which suggests a new board.


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/26 12:22
End of Day Share Price 2024/12/26 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Jiangsu Apon Medical Technology Co., Ltd. is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jiaxi XuIndustrial Securities Co. Ltd.
Wei ZhengTianfeng Securities Brokerage Co., Ltd